Wen-zhe Ma

Title: The Innovative Contributions of Inventor Wen-zhe Ma

Introduction

Wen-zhe Ma, based in Macau, China, is a prominent inventor with a focus on groundbreaking treatments for cancer. His work emphasizes the use of natural compounds derived from citrus fruits, paving the way for more effective cancer therapies. With a total of two patents to his name, Wen-zhe Ma has made significant strides in the fight against multidrug resistance cancer.

Latest Patents

Wen-zhe Ma's latest patents demonstrate his innovative approach to cancer treatment. The first patent addresses the "Use of tangeretin in cancer treatment." This invention reveals a pharmaceutical composition designed to treat multidrug resistance cancer, combining a citrus methoxyflavone, tangeretin, with a chemotherapeutic drug. The patent outlines a method for treating this challenging form of cancer through the administration of both tangeretin and the chemotherapeutic agent.

In his second patent, "Use of nobiletin in cancer treatment," Ma again focuses on multidrug resistance cancer. This patent similarly discloses a pharmaceutical composition that incorporates another citrus methoxyflavone, nobiletin, along with a chemotherapeutic drug. The method for treatment includes the administration of nobiletin and a relevant chemotherapeutic agent, further highlighting Ma's commitment to innovative cancer therapies.

Career Highlights

Wen-zhe Ma is affiliated with the Macau University of Science and Technology, where he collaborates with fellow researchers to advance medicinal chemistry and cancer treatment strategies. His academic and research efforts have not only contributed to the university’s reputation as a leader in scientific innovation but have also positioned him at the forefront of cancer research.

Collaborations

Throughout his career, Wen-zhe Ma has collaborated with esteemed colleagues, including Sen-ling Feng and Zhong-wen Yuan. Together, they have shared insights and expertise, fostering an environment of innovation that is crucial for scientific advancement in their field.

Conclusion

Wen-zhe Ma stands out as an inventive force in the realm of cancer treatment. His patents on tangeretin and nobiletin reflect a forward-thinking approach to combating multidrug resistance cancer. As he continues his work at the Macau University of Science and Technology, Ma's contributions to medical science are likely to inspire further developments in the treatment of cancer. His dedication to innovation and collaboration exemplifies the spirit of modern research, promising a brighter future for cancer therapy.